CTOs on the Move

Allergan

www.allergan.com

 
Allergan is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential — to see more clearly, move more freely, express themselves more fully. Our focus fosters deep engagement with medical specialists and we make it our business to listen closely to their needs so that together we can advance patient care. We combine this strategic focus with a diversified approach that enables us to follow our research and development into new specialty areas where unmet needs are significant. In partnership with the medical ...
  • Number of Employees: 1K-10K
  • Annual Revenue: > $1 Billion
  • www.allergan.com
  • Plaza V Suite 1900
    Jersey City, NJ USA 07311
  • Phone: 201.427.8000

Executives

Name Title Contact Details
Shawn McGuill
Senior Director - Information Security Strategy and Oversight Profile
Michael Towers
Vice President - Chief Information Security Officer Profile
Mengchen Li
Information Security Director Profile
Sue-Jean Lin
Chief Information Officer Profile

Similar Companies

Egenomics

Egenomics is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Abbott Diabetes Care

Abbott Diabetes Care is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

emcresearch

emcresearch is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biospec Products

Biospec Products is a Bartlesville, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tenaya Therapeutics

Tenaya Therapeutics is a biopharmaceutical company dedicated to discovering and developing therapies for heart failure. Tenaya was founded by world-class scientists from the Gladstone Institutes`Cardiovascular Division and UT Southwestern and is backed by The Column Group. Tenaya is building a research-driven organization that targets the fundamental cellular pathologies present in diseased cardiac muscle by leveraging cutting-edge science in cardiac regeneration, induced pluripotent stem cells, and CRISPR technologies.